Heartland Research Associates, LLC

Newton, Kansas 67114-9017

0 studies enrolling now · 34 studies all time

What they study most

Bacterial Vaginosis, Cardiovascular Disease, Chronic Constipation, Chronic Idiopathic Constipation, Diarrhea Predominant Irritable Bowel Syndrome, Dyslipidemias, Episodic Migraine, Growth, Human Metapneumovirus and Human Parainfluenza Infection, Human Papillomavirus Infections, Influenza, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

Studies at this site

• A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older — Completed
• A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
• A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age — Completed
• A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older — Stopped early
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
• Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix — Stopped early
• A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older — Completed
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
• Open Label Safety Study in Acute Treatment of Migraine — Completed
• Safety and Efficacy in Adult Subjects With Acute Migraines — Completed
• Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL — Paused
• Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure — Completed
• Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults — Completed
• Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults — Completed
• SI-613 Study for Knee Osteoarthritis — Completed
• 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine — Completed
• A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age — Completed
• An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation — Completed
• Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) — Completed
• The Plecanatide Chronic Idiopathic Constipation (CIC) Study — Completed
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — Completed
• Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat — Completed
• Growth and Tolerance of Cow's Milk-Based Infant Formulas — Completed
• A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years — Completed
• Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years) — Completed
• Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder — Completed
• Study of Meloxicam Capsules to Treat Osteoarthritis Pain — Completed
• Study of Diclofenac Capsules to Treat Osteoarthritis Pain — Completed
• Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain — Completed
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed
• Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis — Completed